Literature DB >> 15902743

Docetaxel shows radiosensitization in human hepatocellular carcinoma cells.

Chang-Xin Geng1, Zhao-Chong Zeng, Ji-Yao Wang, Shi-Ying Xuan, Chong-Mao Lin.   

Abstract

AIM: To determine the radiosensitizing potential of docetaxel in human hepatocellular carcinoma SMMC-7721 cells and its mechanisms.
METHODS: SMMC-7721 cells were incubated with docetaxel at 0.125, 0.25, and 0.5 nmoL/L for 24 h and at 0.125 and 0.25 nmol/L for 48 h before irradiation. Radiation doses were given from 0 to 10 Gy. Cell survival was measured by a standard clonogenic assay after a 9-d incubation. The reactive oxygen species (ROS) and glutathione (GSH) are detected after being given the same dose of docetaxel for the same time.
RESULTS: The sensitization enhancement ratios (SER) for SMMC-7721 cells determined at the 50% survival level were 1.15, 1.21 and 1.49 at 0.125, 0.25, and 0.5 nmol/L for pre-incubation of 24 h, respectively; the SER were 1.42, 1.67 at 0.125 and 0.25 nmol/L, for pre-incubation of 48 h, respectively. The ROS of SMMC-7721 cells increased and GSH decreased after pretreatment with the same doses of docetaxel for 24 or 48 h.
CONCLUSION: A radiosensitizing effect of docetaxel could be demonstrated unambiguously in this cell line used. In addition, our data showed that the mechanism of radiopotentiation by docetaxel probably does not involve a G2/M block in SMMC-7721 cells, and ROS generation and GSH deletion may play a key role in the radiosensitizing effect of docetaxel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902743      PMCID: PMC4305674          DOI: 10.3748/wjg.v11.i19.2990

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma.

Authors:  W J Guo; E X Yu
Journal:  Br J Radiol       Date:  2000-10       Impact factor: 3.039

2.  Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).

Authors:  O Pradier; M Rave-Fränk; J Lehmann; E Lücke; O Boghun; C F Hess; H Schmidberger
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

3.  Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells.

Authors:  T Noda; R Iwakiri; K Fujimoto; T Y Aw
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

4.  Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change.

Authors:  F Kheradmand; E Werner; P Tremble; M Symons; Z Werb
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

5.  Free radicals generated by ionizing radiation signal nuclear translocation of p53.

Authors:  J D Martinez; M E Pennington; M T Craven; R L Warters; A E Cress
Journal:  Cell Growth Differ       Date:  1997-09

6.  Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione.

Authors:  S N Lavrentiadou; C Chan; T Kawcak; T Ravid; A Tsaba; A van der Vliet; R Rasooly; T Goldkorn
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

7.  Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.

Authors:  Mariko Kito; Yukihiro Akao; Nobuko Ohishi; Kunio Yagi; Yoshinori Nozawa
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

8.  Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells.

Authors:  H M Shen; C F Yang; C N Ong
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

9.  Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species.

Authors:  H L Lin; T Y Liu; G Y Chau; W Y Lui; C W Chi
Journal:  Cancer       Date:  2000-09-01       Impact factor: 6.860

10.  Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens.

Authors:  Roberto Petrioli; Daniele Pozzessere; Simona Messinese; Marianna Sabatino; Federica Ceciarini; Stefania Marsili; Pierpaolo Correale; Anna Ida Fiaschi; Luca Voltolini; Giuseppe Gotti; Guido Francini
Journal:  Lung Cancer       Date:  2003-01       Impact factor: 5.705

View more
  3 in total

1.  Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.

Authors:  Jianqing Lin; Victoria J Sinibaldi; Michael A Carducci; Samuel Denmeade; Danny Song; Theodore Deweese; Mario A Eisenberger
Journal:  Urol Oncol       Date:  2009-12-04       Impact factor: 3.498

2.  Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Pimpicha Patmasiriwat; Frederick E Domann
Journal:  J Oncol       Date:  2012-05-28       Impact factor: 4.375

3.  KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase.

Authors:  Kohei Okuyama; Atsushi Kaida; Yoshiki Hayashi; Yoshio Hayashi; Kiyoshi Harada; Masahiko Miura
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.